Ryo Goto
Chuo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis model.
Journal: Biochemical and biophysical research communications
Published: November 25, 2021
Inhibition of sodium-glucose cotransporter 2 ameliorates renal injury in a novel medaka model of nonalcoholic steatohepatitis-related kidney disease.
Journal: FEBS open bio
Published: July 01, 2019
Efficacy and safety of ribavirin therapy for chronic hepatitis E after kidney transplantation.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: February 14, 2019
Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH).
Journal: FEBS open bio
Published: November 12, 2018
Effective prevention of sorafenib-induced hand-foot syndrome by dried-bonito broth.
Journal: Cancer management and research
Published: May 02, 2018
Autonomic nervous system network and liver regeneration.
Journal: World journal of gastroenterology
Published: March 13, 2018
Effect of histidine on sorafenib-induced vascular damage: Analysis using novel medaka fish model.
Journal: Biochemical and biophysical research communications
Published: December 28, 2017
Effects of Fibrotic Tissue on Liver-targeted Hydrodynamic Gene Delivery.
Journal: Molecular therapy. Nucleic acids
Published: July 07, 2016
Liver-targeted hydrodynamic gene therapy: Recent advances in the technique.
Journal: World journal of gastroenterology
Published: July 04, 2016
Showing 1-10 of 10
Last Updated: 09/26/2026